Compounded Semaglutide and Tirzepatide: What Patients Should Know

You have probably seen it advertised in a Line group, an expat Facebook page, or a Telegram channel: injectable semaglutide at a fraction of what the pen costs, shipped to your condo or available somewhere on Sukhumvit. It looks convenient. The question is whether it is safe, and in Thailand, whether it is even legal.

GLP-1 receptor agonists, the drug class that includes semaglutide and tirzepatide, are effective for weight management when used correctly under medical supervision. The issue is not the drug class. The issue is what you are actually injecting when the product comes from an unlicensed source with no verified supply chain and no clinical oversight.

What Compounding Means in Plain English

A compounding pharmacy takes active pharmaceutical ingredients and prepares a product to order. This is legitimate in specific situations, such as when a patient needs a dose that is not commercially available or has an allergy to a standard product ingredient. Compounding has a real place in medicine.

The problem is when compounding is used simply to make a cheaper copy of an already-available drug. That is a different situation, with different regulatory protections and a different risk profile. Most of what is being sold as compounded semaglutide in Bangkok falls into this second category.

A certificate of analysis, or COA, shows what is actually in a compounded product: potency, purity, and sterility. A legitimate compounding pharmacy provides one for every batch. If a seller cannot produce a COA, that tells you something important.

How Compounded Products Differ From Approved Pens

Ozempic and Wegovy use semaglutide base, the form tested in the large clinical trials that led to regulatory approval. Many compounded vials use a salt form instead, such as semaglutide acetate or semaglutide sodium. These are chemically different. The salt form has not been independently tested for absorption, effectiveness, or safety equivalence to the approved base form. The US FDA has specifically flagged this as a patient safety concern.

The dosing titration schedule, the gradual step-up in dose over weeks, is built into the approved pen format. Each pen is pre-filled to a specific dose. A multi-dose vial with a separate syringe puts the dosing calculation entirely in the patient’s hands. Dosing errors with injectable medications are a well-documented cause of harm, and this risk increases when patients are adjusting based on advice from social media rather than a doctor.

Approved pens are also manufactured under tightly controlled conditions with documented sterility. A compounding pharmacy operates under different standards. If sterility testing has not been done to the level required for injectable products, the infection risk from each injection is real.

Quality, Dosing, and Sterility Concerns

Injectable drugs have no margin for sterility errors. An oral tablet with contamination might cause stomach upset. An injectable with contamination can cause a serious infection at the injection site, or in the worst case, a systemic infection.

Sterile compounding of injectables is governed by strict standards in regulated markets, covering everything from the physical environment of the compounding space to the testing required before a product is released. Third-party potency and sterility testing adds another layer of verification. Products sourced informally through Bangkok’s grey market carry no documentation of any of this.

Before any weight management consultation, use the Doctor Bangkok BMI calculator to get a baseline. It takes thirty seconds and gives your doctor a useful starting point.

What Regulators Have Flagged in Other Markets

The US FDA reported more than a thousand adverse events linked to compounded GLP-1 formulations, including serious hospitalisations. Many involved dosing errors from multi-dose vials, or products where the stated dose did not match what was actually in the vial. The FDA also cited off-label compounding using semaglutide salt as a direct patient safety concern.

In Thailand, the Thai FDA tightened its GLP-1 controls in early 2026, citing self-adjusted dosing driven by social media as a driver of harm. Semaglutide is classified as a special controlled drug. Dispensing it without a licensed prescription is not a grey area.

Abrupt stopping is another risk that rarely comes up in social media discussions. When patients self-source vials and run out, they stop abruptly. Rapid rebound weight gain and return of appetite are well-documented consequences of unsupervised discontinuation. A supervised tapering or transition plan matters.

Safer Compounded Semaglutide Access Through Licensed Prescribing in Bangkok

The right approach is straightforward. See a licensed doctor. Get assessed. Receive a prescription for an approved product, with a proper dosing titration schedule, and have a plan for ongoing monitoring, including a review of your cardiovascular risk alongside your weight management goals.

Doctor Bangkok offers GLP-1 consultations at our clinic on Soi Sukhumvit 13, open 24 hours, and through our doctor-on-call service that brings a physician to your hotel or condo anywhere in Bangkok within the hour. This is particularly relevant for expats who arrived already on a GLP-1 programme and need prescription continuity without a gap in treatment.

You do need a licensed physician who will take a proper history, check for contraindications, and follow up with you. Contraindications include a personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2. A history of pancreatitis requires careful assessment before starting. These are not questions an online vial seller will ask you.

If you want to know exactly what to ask a clinic before accepting any GLP-1 product, the Doctor Bangkok GLP-1 checklist covers sourcing, documentation, and what a legitimate consultation looks like. For a full overview of what supervised treatment involves, see our weight-loss injections page.

DR Ponlawat

Dr. Ponlawat Pitsuwan is a physician at Doctor Bangkok, a private clinic in central Bangkok. He sees expats, residents, and medical tourists for general medicine, wellness consultations, and IV therapy. His focus is straightforward, evidence-based care delivered in plain language.